RIM
AGN

RS Investment Management’s Allergan plc AGN Stock Holding History

RS Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$113M Buy
489,611
+159,021
+48% +$36.7M 1.16% 11
2016
Q1 		$88.6M Sell
330,590
-22,188
-6% -$6.35M 0.88% 20
2015
Q4 		$110M Sell
352,778
-5,610
-2% -$1.67M 0.99% 19
2015
Q3 		$97.4M Sell
358,388
-56,694
-14% -$17.4M 0.87% 21
2015
Q2 		$126M Buy
415,082
+29,516
+8% +$8.8M 1.08% 6
2015
Q1 		$115M Sell
385,566
-28,447
-7% -$8.11M 1.02% 11
2014
Q4 		$107M Sell
414,013
-136,617
-25% -$34.1M 0.95% 14
2014
Q3 		$133M Sell
550,630
-294,767
-35% -$66M 1.23% 5
2014
Q2 		$189M Sell
845,397
-94,285
-10% -$19.5M 1.58% 3
2014
Q1 		$193M Sell
939,682
-118,800
-11% -$23.5M 1.14% 18
2013
Q4 		$178M Buy
1,058,482
+877,648
+485% +$137M 1.09% 18
2013
Q3 		$26M Buy
+180,834
New +$24.1M 0.17% 157

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

RS Investment Management's AGN Position: Q2 2016 in Review

RS Investment Management increased its Allergan plc (AGN) stake by 48% in Q2 2016, buying an estimated $36.7M and bringing the position to 489,611 shares worth $113M. The position accounts for 1.16% of the portfolio, ranked #11.

RS Investment Management first reported a position in AGN in Q3 2013 and has held it in 12 quarters since. The position peaked at $193M in Q1 2014. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • RS Investment Management held 489,611 shares of Allergan plc worth $113M as of Q2 2016.
  • RS Investment Management bought 159,021 Allergan plc shares in Q2 2016, an estimated $36.7M.
  • Allergan plc made up 1.16% of RS Investment Management's portfolio in Q2 2016, its #11 holding.
  • RS Investment Management first reported a position in Allergan plc in Q3 2013 and has held it in 12 quarters since.
  • RS Investment Management's Allergan plc position peaked at $193M in Q1 2014.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.